Swedbank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,355,389
| Closed | -$249M | – | 768 |
|
|
2021
Q2 | $249M | Sell |
1,355,389
-35,889
| -3% | -$6.59M | 0.47% | 42 |
|
|
2021
Q1 | $213M | Sell |
1,391,278
-746,983
| -35% | -$114M | 0.44% | 46 |
|
|
2020
Q4 | $334M | Sell |
2,138,261
-479,333
| -18% | -$74.9M | 0.98% | 27 |
|
|
2020
Q3 | $300M | Sell |
2,617,594
-13,687
| -0.5% | -$1.57M | 1.03% | 23 |
|
|
2020
Q2 | $295M | Sell |
2,631,281
-818,520
| -24% | -$91.9M | 1.07% | 24 |
|
|
2020
Q1 | $310M | Buy |
3,449,801
+256,871
| +8% | +$23.1M | 1.53% | 17 |
|
|
2019
Q4 | $343M | Buy |
3,192,930
+539,356
| +20% | +$57.9M | 1.39% | 15 |
|
|
2019
Q3 | $260M | Buy |
2,653,574
+1,224,177
| +86% | +$120M | 1.18% | 23 |
|
|
2019
Q2 | $187M | Buy |
1,429,397
+698,096
| +95% | +$91.4M | 0.85% | 38 |
|
|
2019
Q1 | $98.9M | Sell |
731,301
-130,044
| -15% | -$17.6M | 0.47% | 78 |
|
|
2018
Q4 | $83.7M | Buy |
861,345
+273,800
| +47% | +$26.6M | 0.46% | 76 |
|
|
2018
Q3 | $81.7M | Sell |
587,545
-233,345
| -28% | -$32.4M | 0.37% | 84 |
|
|
2018
Q2 | $102M | Buy |
+820,890
| New | +$102M | 0.5% | 70 |
|